Citigroup Maintains Buy on Zai Lab, Raises Price Target to $45
Citigroup analyst Yigal Nochomovitz maintains Zai Lab (NASDAQ:ZLAB) with a Buy and raises the price target from $44 to $45.
Read original at benzingaStocks · News reference
Zai Lab Q2 EPS $(0.46) Misses $(0.06) Estimate, Sales $105.751M Beat $105.323M Estimate
Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.06) by 666.67 percent. This is a 24.32 percent decrease over losses of $(0.37) per share from the
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 6, 2026, 10:32 AM
- Checked
- Aug 6, 2026, 10:32 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Zai Lab shares are trading higher after the company reported better-than-expected Q2 sales results.
Read original at benzinga8-K filing — Zai Lab Ltd (ZLAB)
Filed: 2026-08-06 AccNo: 0001628280-26-053791 Size: 395 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgar